How do oncological patients perceive the Covid-19 (SARS-CoV-2) pandemic ? Experience from CHU Liege in Belgium
Concetta Elisa Onesti, Guy Jérusalem(University of Liège), Joëlle Collignon(Centre Hospitalier Universitaire de Liège), L. Nicolaers(Centre Hospitalier Universitaire de Liège), Pierre Frères(Centre Hospitalier Universitaire de Liège), Odile Wéra(Centre Hospitalier Universitaire de Liège), Florence Troisfontaine(Centre Hospitalier Universitaire de Liège), A. Collinge(Centre Hospitalier Universitaire de Liège), M. Goffin(Centre Hospitalier Universitaire de Liège), Anne Sibille, Christine Gennigens(Centre Hospitalier Universitaire de Liège), Marie Lecocq(Centre Hospitalier Universitaire de Liège), Catherine Loly, A. Catot(Centre Hospitalier Universitaire de Liège), Brieuc Sautois(Centre Hospitalier Universitaire de Liège), Andrée Rorive(Centre Hospitalier Universitaire de Liège), Laurence Lousberg(Centre Hospitalier Chrétien), Hélène Schroeder(Centre Hospitalier Universitaire de Liège), Astrid Paulus, Elodie Gonne(Centre Hospitalier Universitaire de Liège)
Open Repository and Bibliography (University of Liège)
January 1, 2020
Cited by 0
Related Papers
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a<i>BRCA1</i>or<i>BRCA2</i>Gene Alteration
|Journal of Clinical Oncology|2020|676
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2021|645
Triple-negative breast cancer: treatment challenges and solutions
|Breast Cancer Targets and Therapy|2016|382
Cardio-Oncology Services: rationale, organization, and implementation
|European Heart Journal|2018|303